MediWound Ltd. is a biotechnology niche specialty company.
Established in 2001, MediWound is committed to develop, manufacture & commercialize global "added value" innovative products to address unmet needs in the fields of burn and wound management.

MediWound's goal is to provide healthcare professionals and patients with its innovative, burn wound debridement agent, Debrase® Gel Dressing - DGD, in order to improve burn wound management and achieving better outcomes.